TRIMTECH Therapeutics
PrivateLast Round
Seed
Jun 23, 2026
Total Funding Raised
$45M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
TRIMTECH Therapeutics operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Seed round in June 2026.
TRIMTECH Therapeutics is a biotechnology company that develops targeted protein degradation therapies to treat neurodegenerative and inflammatory diseases by eliminating toxic protein aggregates.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TRIMTECH Therapeutics Comparables
Compare TRIMTECH Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Convergen Suzhou Pharmaceutical Co. Ltd. | 88% | |
| PAQ Therapeutics | 84% | |
| Plexium | 79% |
For institutional investors. Book with your work email.
TRIMTECH Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 23, 2026 | ||||
| Seed | Mar 5, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
TRIMTECH Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MP Healthcare Venture Management | Seed |
| Start Codon | Seed |
| Cambridge Enterprise Ventures | Seed |
| BGF | Seed |
| M Ventures | Seed |
| Cambridge Innovation Capital | Seed |
| Johnson & Johnson Innovation - JJDC, Inc. | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 76% MoM.
- Jul 28, 2026
Monthly visitors increased 125% MoM, reaching 1.2K.
For institutional investors. Book with your work email.
TRIMTECH Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TRIMTECH Therapeutics's valuation, stock price, and market status.
Is TRIMTECH Therapeutics a public or private company?
TRIMTECH Therapeutics is a private company.
What is the current stock price of TRIMTECH Therapeutics?
TRIMTECH Therapeutics is a private company, so its shares have no public market price. Caplight tracks TRIMTECH Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TRIMTECH Therapeutics worth (valuation)?
Valuation information for TRIMTECH Therapeutics is not publicly available.
Can I buy TRIMTECH Therapeutics stock?
TRIMTECH Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TRIMTECH Therapeutics's last funding round?
TRIMTECH Therapeutics's most recent funding round was Seed on June 23, 2026.
Who are the main investors in TRIMTECH Therapeutics?
Key investors in TRIMTECH Therapeutics include BGF, Cambridge Innovation Capital, Johnson & Johnson Innovation - JJDC, Inc..
Will TRIMTECH Therapeutics IPO soon?
No public IPO plans have been announced for TRIMTECH Therapeutics.
How can I track TRIMTECH Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in TRIMTECH Therapeutics's shares on secondary markets.